CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. (Q33817704)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. |
scientific article |
Statements
CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules (English)
Oumou T Diallo
Michael Hu
Reza Ehsanian
Xinping Yang
Pattatheyil Arun
Hai Lu
Vicci Korman
Khalil Ahmed
Carter Van Waes
6 April 2010
1 reference
1 reference
1 reference